Holen Sie sich die Stockscreener-App
3.96
2.94%
-0.12
Handel nachbörslich:
4.02
0.06
+1.52%
Schlusskurs vom Vortag:
$4.08
Offen:
$4.18
24-Stunden-Volumen:
21,784
Relative Volume:
0.03
Marktkapitalisierung:
$4.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.08M
KGV:
-0.6168
EPS:
-6.42
Netto-Cashflow:
$-11.56M
1W Leistung:
+7.90%
1M Leistung:
-33.11%
6M Leistung:
-75.56%
1J Leistung:
-94.71%
1-Tages-Spanne:
$3.9501
$4.18
1-Wochen-Bereich:
$3.71
$4.29
52-Wochen-Spanne:
$3.50
$75.60
Enveric Biosciences Inc Stock (ENVB) Company Profile
Firmenname
Enveric Biosciences Inc
Sektor
Branche
Telefon
239-302-1707
Adresse
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Vergleichen Sie ENVB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
3.96 | 4.18M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enveric Biosciences Inc Aktie (ENVB) Neueste Nachrichten
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enveric Biosciences, Inc.Common Stock (NQ: ENVB - FinancialContent
Is Enveric Biosciences Inc. stock overvalued by current metricsDurability and Wear Notes & updated model highlights and notes - ulpravda.ru
Can Enveric Biosciences Inc. (SLZ) stock double in coming yearsJuly 2025 Review & Community Trade Idea Sharing Platform - ulpravda.ru
Why Enveric Biosciences Inc. stock remains resilient2025 Winners & Losers & Technical Pattern Alert System - ulpravda.ru
Will Enveric Biosciences Inc. (SLZ) stock benefit from commodity supercycleJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - ulpravda.ru
Is Enveric Biosciences Inc. (SLZ) stock supported by free cash flowPortfolio Profit Report & AI Driven Stock Movement Reports - ulpravda.ru
How institutional buying supports Enveric Biosciences Inc. stockQuarterly Performance Summary & Consistent Return Strategy Ideas - ulpravda.ru
Enveric Biosciences trading halted, volatility trading pause - MSN
2026 world cup team news insights: Is Enveric Biosciences Inc. stock affected by interest rate hikes2026 world cup usa national team qualification key players high defensive line odds analysis guide - ulpravda.ru
Is Enveric Biosciences Inc. stock affected by interest rate hikes2026 world cup usa national team qualification defensive leaders set piece tactics match prediction expert opinion - ulpravda.ru
Dow Theory LettersEnveric Biosciences, Inc.Common Stock (Nasdaq:ENVB) Stock Quote - FinancialContent
Trading Recap: Is Enveric Biosciences Inc SLZ stock undervalued historicallyJuly 2025 Pullbacks & High Conviction Investment Ideas - moha.gov.vn
Enveric Biosciences Inc. (NASDAQ: ENVB)Share Price and Research - intelligentinvestor.com.au
Insider Sell: Will Enveric Biosciences Inc SLZ stock see insider accumulation2025 Earnings Impact & Long-Term Investment Growth Plans - moha.gov.vn
Enveric Biosciences Inc SLZ Stock Analysis and ForecastReal Estate Investment Trusts & Outstanding Growth Opportunities - earlytimes.in
Why did ENVB stock more than double in value today? - MSN
Why Is ENVB Stock Rising Today? - Stocktwits
Why is ENVB stock rising today? - MSN
Top Biotech Stocks To ConsiderDecember 10th - MarketBeat
Enveric Biosciences announces issuance of U.S. patent - Yahoo Finance
ENVERIC BIOSCIENCES, INC. (ENVB) - MSN
Enveric Biosciences Announces Patent Issuance - BioSpace
Enveric Biosciences receives new patent for neuropsychiatric treatments By Investing.com - Investing.com Canada
Enveric Biosciences stock rises after securing patent for novel neurological treatments - Investing.com UK
Enveric Biosciences (ENVB) Secures Patent for Novel Mental Healt - GuruFocus
Enveric Biosciences receives notice of allowance from USPTO for EVM301 series - MSN
Enveric Biosciences (NASDAQ:ENVB) Trading Down 10.9% – What’s Next? - Defense World
Is Enveric Biosciences Inc. stock a dividend growth opportunityMarket Activity Recap & AI Driven Price Predictions - Улправда
Will Enveric Biosciences Inc. stock outperform growth indexesMarket Volume Report & Verified Chart Pattern Trade Signals - Улправда
Is Enveric Biosciences Inc. (SLZ) stock a good hedge against inflationWeekly Profit Recap & Detailed Earnings Play Strategies - Улправда
Momentum Shift: How sustainable is Enveric Biosciences Inc. stock dividend payoutJuly 2025 Outlook & Risk Controlled Stock Pick Alerts - Улправда
Why Enveric Biosciences Inc. stock is recommended by analysts2025 Major Catalysts & Real-Time Volume Triggers - Улправда
How sustainable is Enveric Biosciences Inc. stock dividend payoutJuly 2025 Snapshot & Capital Efficient Trade Techniques - Улправда
Is Enveric Biosciences Inc. stock recession proofDip Buying & AI Enhanced Market Trend Forecasts - Улправда
How strong is Enveric Biosciences Inc. stock balance sheetJuly 2025 Update & Real-Time Price Movement Reports - Улправда
Recap Report: Will Enveric Biosciences Inc. stock outperform growth indexesQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - Улправда
How Enveric Biosciences Inc. stock reacts to job market data2025 Price Momentum & Verified High Yield Trade Plans - Улправда
Enveric Biosciences (ENVB) adds 131,110 shares to 2020 equity incentive plan - Stock Titan
How Enveric Biosciences Inc. stock performs in rate cut cyclesDay Trade & Stepwise Entry/Exit Trade Alerts - Улправда
ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman - Investing News Network
ENvue Medical (NASDAQ: FEED) taps veteran exec David Johnson as chairman - Stock Titan
Enveric Biosciences (STU:SLZ0) Tax Rate % : 0.00% (As of Sep. 2025) - GuruFocus
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds - pharmiweb.com
Enveric Biosciences raises $3.1 million through warrant exercise By Investing.com - Investing.com Nigeria
Enveric Biosciences raises $3.1 million through warrant exercise - Investing.com
Enveric Biosciences (NASDAQ: ENVB) adds new warrants in $3.1M cash deal - Stock Titan
Enveric Biosciences shareholders approve stock issuance and share increase proposals - Investing.com Australia
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds - BioSpace
Finanzdaten der Enveric Biosciences Inc-Aktie (ENVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):